https://investingnews.com/cardiol-therapeutics-receives-nasdaq-deficiency-notice-regarding-minimum-bid-price-requirement/
Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement | INN
Nov 14, 2022 - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical...
cardiol therapeutics
https://investingnews.com/cardiol-therapeutics-files-preliminary-prospectus-supplement-for-proposed-public-offering-of-common-shares/
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common...
Oct 8, 2024 - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical...
cardiol therapeuticspreliminary prospectus
https://www.macrotrends.net/stocks/charts/CRDL/cardiol-therapeutics/revenue
Cardiol Therapeutics Revenue 2022-2026 | CRDL | MacroTrends
Cardiol Therapeutics revenue from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales...
cardiol therapeuticsrevenue20222026crdl
https://www.macrotrends.net/stocks/charts/CRDL/cardiol-therapeutics/debt-equity-ratio
Cardiol Therapeutics Debt to Equity Ratio 2022-2025 | CRDL | MacroTrends
Current and historical debt to equity ratio values for Cardiol Therapeutics (CRDL) over the last 10 years. The debt/equity ratio can be defined as a measure of...
debt to equity ratiocardiol therapeutics20222025crdl
https://www.newsfilecorp.com/release/127137/Cardiol-Therapeutics-Announces-AtTheMarket-Equity-Offering-Program
Cardiol Therapeutics Announces At-The-Market Equity Offering Program
Oakville, Ontario--(Newsfile Corp. - June 9, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
at the marketcardiol therapeuticsannouncesequityoffering
https://www.barchart.com/futures/quotes/CRDL.TO/competitors?quoteSectors=-283E
CRDL.TO Competitors for Cardiol Therapeutics Stock - Barchart.com
Competitors for Cardiol Therapeutics Inc (CRDL.TO): view how companies in the same sector perform against each other.
cardiol therapeuticscrdlcompetitorsstockbarchart
https://www.sofi.com/invest/stock/CRDL/
Buy Cardiol Therapeutics Stock - CRDL Stock Price, Quote & News | SoFi
See real time price charts for CRDL stock, historical data, and recent news. Buy CRDL stock online with no commission fees.
cardiol therapeuticsprice quotebuystockcrdl
https://www.newsfilecorp.com/release/189731/Cardiol-Therapeutics-Announces-Massachusetts-General-Hospital-Largest-Teaching-Hospital-of-Harvard-Medical-School-as-the-8th-Major-Medical-Centre-Participating-in-MAvERICPilot
Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard...
Toronto, Ontario--(Newsfile Corp. - December 5, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
cardiol therapeuticsgeneral hospitalannouncesmassachusettslargest
https://www.ad-hoc-news.de/boerse/news/ueberblick/original-research-cardiol-therapeutics-inc-from-first-berlin-equity/69181650
Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research...
Original-Research: Cardiol Therapeutics Inc - from First Berlin Equity Research GmbH 17.04.2026 / 15:31 CET/CEST Dissemination of a Research, transmitted by...
cardiol therapeutics incoriginal researchvonfirstberlin
https://investingnews.com/cardiol-therapeutics-granted-orphan-drug-designation-for-its-lead-drug-candidate-for-the-treatment-of-pericarditis/
Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment...
Feb 15, 2024 - Designation Based on Pre-Clinical Data and Initial Clinical Data from the Company's MAvERIC-Pilot Phase II StudyThis is a Designated News Release.Cardiol...
orphan drug designationcardiol therapeutics
https://www.newsfilecorp.com/release/189731
Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard...
Toronto, Ontario--(Newsfile Corp. - December 5, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
cardiol therapeuticsgeneral hospitalannouncesmassachusettslargest
https://investingnews.com/stocks/tsx-crdl/cardiol-therapeutics/
Cardiol Therapeutics Stock Price, News, Quote & History | INN
Mar 25, 2026 - Get access to more exclusive Pharmaceutical Investing Stock profiles here
cardiol therapeuticsstock pricequote historynewsinn
https://stockanalysis.com/stocks/crdl/company/
Cardiol Therapeutics (CRDL) Company Profile & Description
Company profile for Cardiol Therapeutics Inc. (CRDL) stock, with a description, list of executives, contact details and other key facts.
cardiol therapeuticscompany profilecrdldescription
https://www.barchart.com/stocks/quotes/CRDL.TO/news
CRDL.TO News for Cardiol Therapeutics - Barchart.com
Latest news headlines for Cardiol Therapeutics Inc with market analysis and analyst commentary.
to newscardiol therapeuticscrdlbarchart
https://www.newsfilecorp.com/release/292336/Cardiol-Therapeutics-to-Highlight-MAVERIC-Phase-III-Trial-and-Recently-Published-ARCHER-Results-in-Live-Interview-with-Barchart
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in...
Toronto, Ontario--(Newsfile Corp. - April 14, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
https://investingnews.com/cardiol-therapeutics-to-webcast-virtual-annual-general-meeting-of-shareholders-on-may-28th-at-4-30-p-m-edt/
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30...
May 27, 2025 - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing...
https://www.biospace.com/press-releases/cardiol-therapeutics-to-webcast-virtual-annual-general-meeting-of-shareholders-on-may-28th-at-4-30-p-m-edt
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30...
https://www.cardiolrx.com/
Home - Cardiol Therapeutics
Jul 6, 2026 - We are a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the...
cardioltherapeutics
https://investingnews.com/cardiol-therapeutics-completes-patient-enrollment-in-its-phase-ii-maveric-pilot-study-investigating-cardiolrx-for-recurrent-pericarditis/
Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating...
Feb 21, 2024 - Topline Results Expected in Q2 2024This is a Designated News Release.Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
https://investingnews.com/cardiol-therapeutics-announces-it-has-exceeded-50-enrollment-in-its-phase-ii-maveric-pilot-study-in-recurrent-pericarditis/
Cardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study...
Nov 20, 2023 - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical...